Liffey Trust Centre

CroíValve is an early stage medical device company focused on developing a minimally invasive device for the treatment of tricuspid regurgitation. CroíValve has developed a highly novel, percutaneous solution to treat Tricuspid Regurgitation. It can be delivered through a vein and into the right heart, restoring the function of the tricuspid valve. The device seals the central gap between the native valve leaflets preventing regurgitation.